This report examines the current and future market potential of COVID-19 diagnostics. It offers an analysis of the competitive environment, regulatory scenario, technologies, and the drivers and restraints in the market’s growth. The report also covers market projections to 2025 and market rankings for key players. The report examines the market share of COVID-19 diagnostics based on the type of products, type of testing and end-user.
This report segments the global market by four regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. The European region includes Germany, U.K., France, and the Rest of Europe. The Asia-Pacific region includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data is provided for the base year of 2020 and forecast through year-end 2025.
Report Includes:
- 48 data tables and 34 additional tables
- An overview of the global market for COVID-19 diagnostics and kits
- Estimation of the market size and analyses of global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of current market size and forecast, pipeline analysis of new products, and regulatory scenarios and detailed analysis of drivers, challenges and opportunities affecting the market growth
- Details about outbreak, symptoms, progression, incubation period and epidemiology of COVID-19; coverage of global confirmed COVID-19 cases and deaths; information on the collaboration between organizations and governments; and impact of COVID-19 pandemic on Medtech and medical tourism
- A look at how pandemics adversely affect the health of the global population and destabilizes the world’s economies, social infrastructures, and geopolitical and natural environments
- Highlights of the coronavirus treatment acceleration Program (CTAP) and coverage of ongoing clinical trials of national regulatory agencies during the COVID-19 pandemic
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry, including Abbott, Becton, Dickinson and Co., Cepheid, Roche, PerkinElmer and Thermo Fisher Scientific
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
- Highlights of the Market for COVID-19 Diagnostics
Chapter 3 COVID-19 and R&D Efforts
- Potential Targets for COVID-19 Drug Development
- Basigin (CD147)
- C-C Chemokine Receptor Type 5 (CCR5)
- Envelope Protein (E) (SARS-CoV-2; COVID-19)
- Epithelial Sodium Channel (ENaC)
- Histamine N-Methyltransferase (HMT)
- Interleukin-6 Receptor Subunit a (IL-6RA)
- Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
- Nucleocapsid (N) (SARS-CoV-2; COVID-19)
- R&D on COVID-19
- Need to Reinvent Ventilators
- COVID-19 Clinical Trial Landscape
Chapter 4 Regulatory Structure of the COVID-19 Diagnostics Industry
- Coronavirus Treatment Acceleration Program (CTAP)
- Clinical Trials Being Conducted During COVID-19 Pandemic
- Response to Drug Shortages
- National Regulatory Agencies for Ongoing Clinical Trials During the COVID-19 Pandemic
- U.S. FDA
- Medicines and Healthcare Products Regulatory Agency (U.K.)
- European Medicines Agency
Chapter 5 Medical Device Regulations
- Medical Device Definition and Classification
- Regulations
- U.S.
- Europe
Chapter 6 COVID-19 Diagnostics: Market Dynamics
- Market Dynamics
- Market Drivers
- Key Developments and Support by Non-medical Device/Diagnostic Companies
- Market Restraints
- Restrictions on Export of Diagnostic Kits
- Accuracy of Test Results
- Market Opportunities
- Development of Quick, Accurate and Affordable Tests
- Strategic R&D Initiatives
Chapter 7 Impact of COVID-19 Pandemic
- Introduction
- Outbreak
- Symptoms of COVID-19
- Progression of COVID-19
- Incubation Period
- Epidemiology
- Collaboration Between Organizations and Governments
- Spread of Disease
- Current Status and Impact on Medical Technology
- Elective and Noncritical Procedures
- Shift in Manufacturing
- Regulatory Delays, Clinical Trials, and Product Launches
- Supply Chain Disruptions
- Medical Tourism
Chapter 8 Market Breakdown by Product Type
- Global Market for COVID-19 Diagnostics, by Product Type
- Reagents and Kits
- Market Size and Forecast
- Market Analysis
- COVID-19 Diagnostics Instruments
- Market Size and Forecast
- Market Analysis
Chapter 9 Market Breakdown by Testing Type
- Global Market for COVID-19 Diagnostics, by Testing Type
- Molecular Testing (RNA or PCR Test)
- Market Size and Forecast
- Market Analysis
- Antigen Testing
- Market Size and Forecast
- Market Analysis
- Antibody Testing
- Market Size and Forecast
- Market Analysis
Chapter 10 Market Breakdown by End User
- Global Market for COVID-19 Diagnostics by End User
- Hospitals
- Market Size and Forecast
- Market Analysis
- Diagnostic Centers and Clinics
- Market Size and Forecast
- Market Analysis
Chapter 11 Market Breakdown by Region
- Global Market for COVID-19 Diagnostics, by Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
Chapter 12 Competitive Landscape
- Analysis of Market Shares of Global Companies
- Pricing of COVID-19 Diagnostics
- Competitors
- New Product Approvals
Chapter 13 Company Profiles
- 1Drop Diagnostics
- Abbott
- Becton, Dickinson And Co.
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Cepheid
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Genmark Diagnostics Inc.
- Hologic Inc.
- Laboratory Corp. Of America
- Perkinelmer Inc.
- Quest Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
- Veredus Laboratories
Chapter 14 Appendix: List of Acronyms
List of Tables
Summary Table C: Global Market for COVID-19 Diagnostics, by End User, Through 2025
Summary Table A: Global Market for COVID-19 Diagnostics, by Product Type, Through 2025
Summary Table B: Global Market for COVID-19 Diagnostics, by Testing Type, Through 2025
Table 1: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
Table 2: COVID-19 Therapeutics in Development, by Biopharmaceutical Company
Table 3: COVID-19 Vaccines in Development, by Biopharmaceutical Companies in Collaboration
Table 4: COVID-19 Vaccines in Development, by Biopharmaceutical Company
Table 5: Modifiable Breathing Devices Eligible for Emergency Use Authorization (EUA), by Company
Table 6: Clinical Trials on COVID-19, by Phase
Table 7: Clinical Trials on COVID-19, by Intervention
Table 8: Clinical Trials on COVID-19, by Country
Table 9: Class I and Class II Exempt Devices
Table 10: Total Number of COVID-19 Confirmed Cases and Deaths Globally, by Country, March 15, 2021
Table 11: Test Kit Manufacturers and EUA Authorizations
Table 12: Distribution of COVID-19 Clinical Symptoms
Table 13: Total Number of COVID-19 Confirmed Cases and Deaths Worldwide, by Region, March 15, 2021
Table 14: Total Number of Diagnostic Tests Performed Per 1 Million Population in Selected Countries, March 8, 2021
Table 15: Global Market for COVID-19 Diagnostics, by Product Type, Through 2025
Table 16: Global Market for Reagents and Kits, by Region, Through 2025
Table 17: North American Market for Reagents and Kits, by Country, Through 2025
Table 18: European Market for Reagents and Kits, by Country, Through 2025
Table 19: Asia-Pacific Market for Reagents and Kits, by Country, Through 2025
Table 20: Global Market for COVID-19 Diagnostics Instruments, by Region, Through 2025
Table 21: North American Market for COVID-19 Diagnostics Instruments, by Country, Through 2025
Table 22: European Market for COVID-19 Diagnostics Instruments, by Country, Through 2025
Table 23: Asia-Pacific Market for COVID-19 Diagnostics Instruments, by Country, Through 2025
Table 24: COVID-19 Diagnostics Testing Basics
Table 25: Global Market for COVID-19 Diagnostics, by Testing Type, Through 2025
Table 26: Global Market for Molecular Testing, by Region, Through 2025
Table 27: North American Market for Molecular Testing, by Country, Through 2025
Table 28: European Market for Molecular Testing, by Country, Through 2025
Table 29: Asia-Pacific Market for Molecular Testing, by Country, Through 2025
Table 30: Global Market for Antigen Testing, by Region, Through 2025
Table 31: North American Market for Antigen Testing, by Country, Through 2025
Table 32: European Market for Antigen Testing, by Country, Through 2025
Table 33: Asia-Pacific Market for Antigen Testing, by Country, Through 2025
Table 34: Global Market for Antibody Testing, by Region, Through 2025
Table 35: North American Market for Antibody Test, by Country, Through 2025
Table 36: European Market for Antibody Testing, by Country, Through 2025
Table 37: Asia-Pacific Market for Antibody Testing, by Country, Through 2025
Table 38: Global Market for COVID-19 Diagnostics, by End User, Through 2025
Table 39: Global Market for COVID-19 Diagnostics Used in Hospitals, by Region, Through 2025
Table 40: North American Market for COVID-19 Diagnostics Used in Hospitals, by Country, Through 2025
Table 41: European Market for COVID-19 Diagnostics Used in Hospitals, by Country, Through 2025
Table 42: Asia-Pacific Market for COVID-19 Diagnostics Used in Hospitals, by Country, Through 2025
Table 43: Global Market for COVID-19 Diagnostics Used in Diagnostic Centers and Clinics, by Region, Through 2025
Table 44: North American Market for COVID-19 Diagnostics Used in Diagnostic Centers and Clinics, by Country, Through 2025
Table 45: European Market for COVID-19 Diagnostics Used in Diagnostic Centers and Clinics, by Country, Through 2025
Table 46: Asia-Pacific Market for COVID-19 Diagnostics Used in Diagnostic Centers and Clinics, by Country, Through 2025
Table 47: Global Market for COVID-19 Diagnostics, by Region, Through 2025
Table 48: North American Market for COVID-19 Diagnostics, by Country, Through 2025
Table 49: European Market for COVID-19 Diagnostics, by Country, Through 2025
Table 50: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2025
Table 51: Company Shares of Global COVID-19 Diagnostics Market, 2020
Table 52: Companies Offering COVID-19 Diagnostics
Table 53: Recent Product Approvals on COVID-19 Diagnostics, 2020
Table 54: Abbott: Financials, 2016-2019
Table 55: Abbott: Product Portfolio, by Business Segment
Table 56: Abbott: Recent Developments
Table 57: Becton, Dickinson: Business Segment
Table 58: Becton, Dickinson: COVID-19 Diagnostics
Table 59: Becton, Dickinson: Recent Developments, August 2015-April 2020
Table 60: BioMerieux SA: Financials, 2018
Table 61: BioMerieux SA: Products and Services
Table 62: BioMerieux SA: Recent Developments, November 2018-March 2020
Table 63: Bio-Rad Laboratories: Products and Services
Table 64: Bio-Rad Laboratories: SARS-CoV-2/COVID-19 Diagnosis and Confirmation Solutions
Table 65: Danaher: COVID-19 Diagnostics Products
Table 66: Danaher: Recent Developments
Table 67: F. Hoffmann-La Roche: Product Portfolio
Table 68: F. Hoffmann-La Roche: COVID-19 Diagnostics Product
Table 69: F. Hoffmann-La Roche Ltd.: Recent Developments, January 2015-April 2020
Table 70: GenMark Diagnostics: COVID Diagnostic Product
Table 71: GenMark Diagnostics: Financials, 2019
Table 72: Hologic: Financials, 2019
Table 73: Hologic: Recent Developments and Strategies, March 2017-March 2020
Table 74: Siemens Healthineers: Product Segments
Table 75: Siemens Healthcare AG: Financials, 2019
Table 76: Siemens Healthcare AG: Recent Developments, March 2016-March 2020
Table 77: Thermo Fisher Scientific: Product Portfolio
Table 78: Thermo Fisher Scientific: Covid Products
Table 79: Acronyms Used in the COVID-19 Diagnostics Market
List of Figures
Summary Figure A: Global Market for COVID-19 Diagnostics, by Product Type, 2020-2025
Summary Figure B: Global Market for COVID-19 Diagnostics, by Testing Type, 2020-2025
Summary Figure C: Global Market for COVID-19 Diagnostics, by End User, 2020-2025
Figure 1: Distribution of Clinical Trials on COVID-19, by Phase
Figure 2: Distribution of Clinical Trials on COVID-19, by Intervention
Figure 3: Distribution of Clinical Trials on COVID-19, by Country
Figure 4: Process for Marketing a Medical Device in the U.S.
Figure 5: Global Market Shares of COVID-19 Diagnostics, by Product Type, 2020
Figure 6: Global Market for Reagents and Kits, by Region, 2020-2025
Figure 7: Global Market for COVID-19 Diagnostics Instruments, by Region, 2020-2025
Figure 8: Global Market Shares of COVID-19 Diagnostics, by Testing Type, 2020
Figure 9: Global Market for Molecular Testing, by Region, 2020-2025
Figure 10: Global Market for Antigen Testing, by Region, 2020-2025
Figure 11: Global Market for Antibody Testing, by Region, 2020-2025
Figure 12: Global Market Shares of COVID-19 Diagnostics, by End User, 2020
Figure 13: Global Market for COVID-19 Diagnostics Used in Hospitals, by Region, 2020-2025
Figure 14: Global Market for COVID-19 Diagnostics Used in Diagnostic Centers and Clinics, by Region, 2020-2025
Figure 15: Global Market Shares of COVID-19 Diagnostics Market, by Region, 2020
Figure 16: North American Market Shares for COVID-19 Diagnostics, by Country, 2025
Figure 17: U.S. Market for COVID-19 Diagnostics, 2020-2025
Figure 18: Canadian Market for COVID-19 Diagnostics, 2020-2025
Figure 19: Mexican Market for COVID-19 Diagnostics, 2020-2025
Figure 20: European Market Shares for COVID-19 Diagnostics, by Country, 2020
Figure 21: German Market for COVID-19 Diagnostics, 2020-2025
Figure 22: U.K. Market for COVID-19 Diagnostics, 2020-2025
Figure 23: French Market for COVID-19 Diagnostics, 2020-2025
Figure 24: Rest of European Market for COVID-19 Diagnostics, 2020-2025
Figure 25: Asia-Pacific Market Shares for COVID-19 Diagnostics, by Country, 2018
Figure 26: Japanese Market for COVID-19 Diagnostics, 2020-2025
Figure 27: Chinese Market for COVID-19 Diagnostics, 2020-2025
Figure 28: Indian Market for COVID-19 Diagnostics, 2020-2025
Figure 29: Rest of Asia-Pacific Market for COVID-19 Diagnostics, 2020-2025
Figure 30: Rest of the World Market for COVID-19 Diagnostics, 2020-2025
Figure 31: Abbott: Annual Revenue, 2017-2019
Figure 32: Abbott: Revenue Share, by Region/Country, 2019
Figure 33: Abbott: Revenue Share, by Business Segment, 2019
Figure 34: Becton, Dickinson: Annual Revenue, 2018-2020
Figure 35: Becton, Dickinson: Revenue Share, by Business Unit, 2020
Figure 36: Becton, Dickinson: Revenue Share, by Geography, 2020
Figure 37: BioMerieux SA: Revenue, by Business Segment, 2015-2017
Figure 38: BioMerieux SA: Revenue, by Region, 2015-2017
Figure 39: Bio-Rad Laboratories: Annual Revenue, 2018-2020
Figure 40: Bio-Rad Laboratories: Revenue Share, by Business Segment, 2020
Figure 41: Danaher: Annual Revenue, 2017-2019
Figure 42: Danaher: Revenue Share, by Business Segment, 2019
Figure 43: F. Hoffmann-La Roche: Annual Revenue, 2018-2020
Figure 44: F. Hoffmann-La Roche: Revenue Share, by Segment, 2020
Figure 45: Hologic: Financials, 2014-2019
Figure 46: Hologic: Revenue Share, by Region, 2019
Figure 47: Hologic Inc.: Revenue Share, by Segment, 2019
Figure 48: Siemens Healthcare AG: Revenue Share, by Business Segment, 2019
Figure 49: Siemens Healthcare AG: Revenue Share, by Region, 2019
Figure 50: Thermo Fisher Scientific: Annual Revenue, 2018 and 2019
Figure 51: Thermo Fisher Scientific: Revenue Share, by Product Category, 2019
Executive Summary
Reasons for Doing This Study:
Pandemics are outbreaks of disease that become widespread via human-to-human infection. Recent disease outbreaks and pandemics include the Spanish flu, the Hong Kong flu, SARS, H7N9, Ebola and Zika (WHO, 2011b). The main features of a pandemic include broad geographic spread, disease movement, novelty, intensity, high attack rates and explosivity, limited population immunity, infectiousness and contagiousness. Pandemics have adversely affected the health of the planet’s inhabitants and have destabilized the world’s economies, social infrastructures, and geopolitical and natural environments. In China, in December 2019, the new coronavirus disease was detected for the first time. As of March 2021, it continues to affect people across the globe. Early and accurate diagnosis of COVID-19 (the disease caused by an infection with the new coronavirus) is critical to controlling its spread and improving health outcomes.
With the spread of COVID-19, the demand for molecular testing, which is considered the gold standard for diagnosing infectious disease, has increased. In the U.S. and Europe alone, the use of molecular diagnostics increased by 20% between March 2020 and October 2020. The volume of point-of-care (POC) testing has risen during the COVID-19 pandemic in response to demand for faster on-site screening. The response to that has been the accelerated development of new diagnostic technologies, such as next-generation sequencing (NGS) and CRISPR. Those technologies could soon challenge the leading position of the current RT-PCR systems for viral COVID-19 tests, particularly if regulators further facilitate their rapid introduction.
The growth of the global COVID-19 diagnostics market is being fueled by several factors, including the increasing numbers of COVID 19 cases; government and private funds to support the R&D of COVID-19 test kits and vaccines; the rising number of emergency use authorizations (EUAs) for diagnostic kits and devices; the growing geriatric population; and increasing support by non-medical device and diagnostics companies.
Companies Mentioned
- 1Drop Diagnostics
- Abbott
- Becton, Dickinson And Co.
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Cepheid
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Genmark Diagnostics Inc.
- Hologic Inc.
- Laboratory Corp. Of America
- Perkinelmer Inc.
- Quest Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
- Veredus Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | April 2021 |
| Forecast Period | 2020 - 2025 |
| Estimated Market Value ( USD | $ 10.8 Billion |
| Forecasted Market Value ( USD | $ 12 Billion |
| Compound Annual Growth Rate | 2.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
